0001628280-24-029656.txt : 20240624 0001628280-24-029656.hdr.sgml : 20240624 20240624174731 ACCESSION NUMBER: 0001628280-24-029656 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240620 FILED AS OF DATE: 20240624 DATE AS OF CHANGE: 20240624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xian Ming CENTRAL INDEX KEY: 0001743879 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31573 FILM NUMBER: 241065603 MAIL ADDRESS: STREET 1: MEDIFAST, INC. STREET 2: 100 INTERNATIONAL DRIVE, 18TH FLOOR CITY: BALTIMORE STATE: MD ZIP: 21202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIFAST INC CENTRAL INDEX KEY: 0000910329 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 133714405 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11445 CRONHILL DRIVE CITY: OWINGS MILLS STATE: MD ZIP: 21117 BUSINESS PHONE: 7327640619 MAIL ADDRESS: STREET 1: 11445 CRONHILL DRIVE CITY: OWINGS MILLS STATE: MD ZIP: 21117 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHRITE INC DATE OF NAME CHANGE: 19951120 FORMER COMPANY: FORMER CONFORMED NAME: XX DATE OF NAME CHANGE: 19950619 FORMER COMPANY: FORMER CONFORMED NAME: 00 DATE OF NAME CHANGE: 19950619 4 1 wk-form4_1719265644.xml FORM 4 X0508 4 2024-06-20 0 0000910329 MEDIFAST INC MED 0001743879 Xian Ming C/O MEDIFAST, INC. 100 INTERNATIONAL DRIVE BALTIMORE MD 21202 1 0 0 0 0 Restricted Stock Units (cash settled) 2024-06-20 4 A 0 10149 0 A Common Stock 10149 14961.918 D Represents the contingent right to receive 10,149 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan. /s/ Jason L. Groves, attorney-in-fact 2024-06-24